• Current Issue:
    5articles Vol.4(2024)
    Sort by
    Open Access
    Targeted treatments for immune dysregulation in inborn errors of immunity
    Primary immune regulatory disorders (PIRDs) constitute a subset of inborn errors of immunity and are characterized by lymphoproliferation, autoimmunity, malignancy, and infection. Unlike classical p [...] Read more.
    Nadia Makkoukdji ... Melissa Gans
    Published: April 23, 2024 Explor Immunol. 2024;4:218–237
    DOI: https://doi.org/10.37349/ei.2024.00138
    Times Cited: 0
    Open Access
    Dendritic cell and co-stimulatory molecule targeted therapy for autoimmune diseases: a review of the newly implemented strategies
    Dendritic cells (DCs) play an important role in the formation of the immune response, and they are involved in the pathogenesis of autoimmune diseases. Targeting DCs has thus emerged as a new therap [...] Read more.
    Mazen El Jamal, Farah Shibli
    Published: April 02, 2024 Explor Immunol. 2024;4:189–210
    DOI: https://doi.org/10.37349/ei.2024.00136
    This article belongs to the special issue Immunobiology of Dendritic Cells
    Times Cited: 0
    Open Access
    Cancer stem cell, chromosomal instability, and cancer immunity
    Cancer stem cells (CSCs) are a unique population of tumor cells with stem cell-like properties. They are believed to be involved in drug resistance, potential therapy failure, tumor relapse after tr [...] Read more.
    Laxmi Kumari ... Alka Bhatia
    Published: April 02, 2024 Explor Immunol. 2024;4:169–188
    DOI: https://doi.org/10.37349/ei.2024.00135
    Times Cited: 0
    Open Access
    Entrance to the multifaceted world of CD4+ T cell subsets
    This review provides a detailed examination of CD4+ T lymphocyte subsets, crucial components of the immune system originating from the thymus. This study explores the distinct roles and mechanisms o [...] Read more.
    Murilo Porfírio de Aguiar, Julia Hailer Vieira
    Published: March 05, 2024 Explor Immunol. 2024;4:152–168
    DOI: https://doi.org/10.37349/ei.2024.00134
    Times Cited: 0